Controlled Substances Act Clarification in Sciences Act of 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Email me when HR 9186 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 9186. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill adds new, science‑based definitions to the Controlled Substances Act and tells the Attorney General to rely on the Health Secretary’s evaluation when placing drugs in schedules. It aims to keep harmful substances controlled while preserving access for legitimate medical and research uses. This could change how drugs are classified and affect patients, doctors, researchers, and law‑enforcement.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 9186
3 free questions a day, no accountSponsors
- Rep. Cohen, Steve [D-TN-9] (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 9186 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 9186 freeOr ask your AI assistant about HR 9186 directly:
Add to Claude, ChatGPT or Cursor